FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry and represents a pharmaceutical composition in the form of a liquid solution for nasal administration of spray containing naltrexone in an amount of 0.005-0.02 wt/vl %.
EFFECT: invention provides eliminating the undesired side effects with preserving naltrexone activity.
6 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS, DEVICES AND METHODS FOR THE TREATMENT OF ALCOHOL DEPENDENCE | 2017 |
|
RU2767062C2 |
| COMPOSITIONS AND METHODS OF TREATING OPIOID OVERDOSE | 2017 |
|
RU2769397C2 |
| PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2445077C2 |
| COMBINATIONS OF AGONIST/ANTAGONIST FOR OPIOID | 1998 |
|
RU2241458C2 |
| ENANTIOMERICALLY PURE OPIOID DIARYLMETHYL PIPERAZINE AND METHODS FOR USES THEREOF | 2002 |
|
RU2309153C2 |
| FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USING THEM | 2007 |
|
RU2539387C2 |
| EXTENDED-RELEASE INJECTION COMPOSITION OF NALTREXONE | 2019 |
|
RU2806817C2 |
| PHARMACEUTICAL PREPARATIVE FORM | 2004 |
|
RU2362560C2 |
| COMPOSITIONS AND METHOD FOR RELIEVING RESPIRATORY DISTRESS CAUSED BY OPIOID OVERDOSE | 2011 |
|
RU2541159C2 |
| INTRANASAL DEXMEDETOMIDINE COMPOSITIONS AND METHODS OF USE THEREOF | 2012 |
|
RU2692245C2 |
